Patent Application
Provisional
Small
App. No. 63/029,503
· Confirmation No. 1904
Use of Arginase for Treatment of Coronavirus Infection
Applicant:
Aeglea BioTherapeutics, Inc.
Provisional Application Expired
|
⬇ PDF
|
Code | Description | Pages | ||
|---|---|---|---|---|---|
| 2020-06-04 | APP.FILE.REC |
Filing Receipt | 3 | View | |
| 2020-05-24 | ADS |
Application Data Sheet | 8 | View | |
| 2020-05-24 | DRW |
Drawings-only black and white line drawings | 33 | View | |
| 2020-05-24 | ABST |
Abstract | 1 | View | |
| 2020-05-24 | CLM |
Claims | 2 | View | |
| 2020-05-24 | SPEC |
Specification | 62 | View | |
| 2020-05-24 | WFEE |
Fee Worksheet (SB06) | 2 | View | |
| 2020-05-24 | N417 |
Electronic Filing System Acknowledgment Receipt | 3 | View |
Inventors
Scott W. Rowlinson
Austin, TX
Mark Badeaux
Austin, TX
Attorneys & Agents of Record
Prosecution
- Customer No.
- 48394
- Docket No.
- A0021-00-P2
- Confirmation No.
- 1904
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded 2023-10-02
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this application's details
Quick Facts
- App. No.
- 63/029,503
- Filed
- 2020-05-24
External Links